Shanghai Haohai Biological Technology Co., Ltd. (688366.SS)
CNY 62.26
(-0.91%)
CNY 62.26
(-0.91%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.85 Billion CNY | 28.1% |
| 2022 | 1.44 Billion CNY | 14.86% |
| 2021 | 1.25 Billion CNY | 27.19% |
| 2020 | 990.42 Million CNY | -19.58% |
| 2019 | 1.23 Billion CNY | 1.65% |
| 2018 | 1.21 Billion CNY | 14.58% |
| 2017 | 1.05 Billion CNY | 49.01% |
| 2016 | 709.6 Million CNY | 26.98% |
| 2015 | 558.84 Million CNY | 24.17% |
| 2014 | 450.05 Million CNY | 29.98% |
| 2013 | 346.25 Million CNY | 36.99% |
| 2012 | 252.75 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 504.66 Million CNY | 13.68% |
| 2024 Q3 | 466.26 Million CNY | -7.61% |
| 2024 Q1 | 443.92 Million CNY | 8.34% |
| 2023 FY | 1.85 Billion CNY | 28.1% |
| 2023 Q4 | 409.75 Million CNY | -16.97% |
| 2023 Q3 | 493.47 Million CNY | 5.88% |
| 2023 Q2 | 466.05 Million CNY | 14.12% |
| 2023 Q1 | 408.37 Million CNY | 20.74% |
| 2022 FY | 1.44 Billion CNY | 14.86% |
| 2022 Q4 | 338.21 Million CNY | -23.47% |
| 2022 Q3 | 441.92 Million CNY | 37.09% |
| 2022 Q2 | 322.36 Million CNY | 14.43% |
| 2022 Q1 | 281.71 Million CNY | -2.71% |
| 2021 Q3 | 275.49 Million CNY | -15.78% |
| 2021 Q4 | 289.57 Million CNY | 5.11% |
| 2021 FY | 1.25 Billion CNY | 27.19% |
| 2021 Q2 | 327.11 Million CNY | 23.0% |
| 2021 Q1 | 265.95 Million CNY | -12.98% |
| 2020 Q1 | 116.28 Million CNY | -66.42% |
| 2020 Q4 | 305.62 Million CNY | -0.93% |
| 2020 Q3 | 308.48 Million CNY | 18.64% |
| 2020 Q2 | 260.02 Million CNY | 123.6% |
| 2020 FY | 990.42 Million CNY | -19.58% |
| 2019 Q4 | 346.3 Million CNY | 21.84% |
| 2019 FY | 1.23 Billion CNY | 1.65% |
| 2019 Q1 | 235.47 Million CNY | -22.64% |
| 2019 Q3 | 284.23 Million CNY | -22.23% |
| 2019 Q2 | 365.47 Million CNY | 55.2% |
| 2018 FY | 1.21 Billion CNY | 14.58% |
| 2018 Q4 | 304.39 Million CNY | 0.0% |
| 2018 Q3 | 304.39 Million CNY | 1.0% |
| 2018 Q1 | 301.37 Million CNY | 4.0% |
| 2018 Q2 | 301.37 Million CNY | 0.0% |
| 2017 FY | 1.05 Billion CNY | 49.01% |
| 2017 Q4 | 289.77 Million CNY | 0.0% |
| 2017 Q3 | 289.77 Million CNY | 21.29% |
| 2017 Q2 | 238.91 Million CNY | 0.0% |
| 2017 Q1 | 238.91 Million CNY | 19.78% |
| 2016 Q2 | 155.33 Million CNY | 0.0% |
| 2016 Q4 | 199.46 Million CNY | 0.0% |
| 2016 Q3 | 199.46 Million CNY | 28.41% |
| 2016 Q1 | 155.33 Million CNY | 6.2% |
| 2016 FY | 709.6 Million CNY | 26.98% |
| 2015 FY | 558.84 Million CNY | 24.17% |
| 2015 Q3 | 146.27 Million CNY | 9.86% |
| 2015 Q2 | 133.14 Million CNY | 0.0% |
| 2015 Q1 | 133.14 Million CNY | 7.42% |
| 2015 Q4 | 146.27 Million CNY | 0.0% |
| 2014 Q1 | 101.07 Million CNY | 6.99% |
| 2014 Q4 | 123.95 Million CNY | 0.0% |
| 2014 Q2 | 101.07 Million CNY | 0.0% |
| 2014 FY | 450.05 Million CNY | 29.98% |
| 2014 Q3 | 123.95 Million CNY | 22.64% |
| 2013 Q2 | 78.65 Million CNY | 0.0% |
| 2013 Q3 | 94.47 Million CNY | 20.11% |
| 2013 Q4 | 94.47 Million CNY | 0.0% |
| 2013 FY | 346.25 Million CNY | 36.99% |
| 2013 Q1 | 78.65 Million CNY | 0.0% |
| 2012 FY | 252.75 Million CNY | 0.0% |